News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
261 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17894)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (335)
2 (311)
3 (237)
4 (70)
6 (2)
7 (48)
8 (54)
9 (56)
10 (84)
11 (40)
13 (1)
14 (80)
15 (90)
16 (78)
17 (59)
18 (31)
20 (1)
21 (91)
22 (78)
23 (75)
24 (68)
25 (25)
26 (1)
28 (4)
29 (222)
30 (262)
31 (261)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
6
7
8
9
10
11
13
14
15
16
17
18
20
21
22
23
24
25
26
28
29
30
31
Business
Cantel Medical Reports Financial Results for its Third Quarter Fiscal Year 2018
Cantel Medical Corp. (NYSE: CMD) today announced financial results for its third quarter ended April 30, 2018.
May 31, 2018
·
14 min read
Biotech Bay
Qardio Brings the Power of its Digital Health Solutions to Doctors Interested in Billing for Remote Care
Qardio announced a new service for remote monitoring that brings a smarter way for doctors to deliver non face-to-face patient care while increasing revenue opportunities with the new reimbursement CPT code 99091.
May 31, 2018
·
2 min read
Business
Cingulate Therapeutics Strengthens Leadership with Two New Board Appointments
Cingulate Therapeutics LLC, a clinical stage biopharmaceutical company focused on the development of new and innovative products utilizing its precision timed release drug delivery platform technology, today announced the appointment of Jeff Conroy and Jeff Hargroves to its Board of Directors
May 31, 2018
·
3 min read
Business
LYONBIOPOLE Will Unite Leading French Biotech Actors at the 2018 BIO International Convention
Lyonbiopole the French “bio-cluster” based in the Auvergne-Rhône-Alpes region, will unite 35 innovative organizations at the 2018 edition of the BIO International Convention.
May 31, 2018
·
2 min read
Genetown
Bicycle Therapeutics and Cancer Research UK Announce Presentation at 2018 American Society of Clinical Oncology Meeting
Cancer Research UK and Bicycle Therapeutics announced a poster presentation at the 2018 Annual Meeting of the American Society of Clinical Oncology.
May 31, 2018
·
5 min read
Genetown
Tarveda Therapeutics to Present at Jefferies 2018 Global Healthcare Conference
Tarveda Therapeutics, Inc. announced that Drew Fromkin, President and Chief Executive Officer, will present at the Jefferies 2018 Global Healthcare Conference.
May 31, 2018
·
2 min read
IAVI, Selexis SA and Collaborators Publish Study Highlighting Improved Approach for Generating Complex Proteins Required for Producing HIV Vaccines
Paper in Frontiers in Immunology Describes Trimer Design and Development of Production CHO Cell Lines That Generate Properly Folded HIV-1 Env Trimers to Support Goal of Developing an Effective HIV Vaccine
May 31, 2018
·
4 min read
Business
ArunA Biomedical Appoints Industry Veteran Skip Irving to Board of Directors
Mr. Irving has overseen business strategy, R&D planning, product commercialization and business development for companies of all sizes for over 35 years, with an interest in neuroscience.
May 31, 2018
·
3 min read
Business
RRD International Appoints Bridget Martell, M.D. as Chief Medical Officer and Promotes Maryann Krane to Senior Vice President, Program Leadership
Bridget and Maryann contribute veteran expertise and strategic perspective as we help biopharmaceutical companies and investors make more efficient use of capital and accelerate product development.
May 31, 2018
·
3 min read
Drug Development
/C O R R E C T I O N -- Curis, Inc./ Curis Announces FDA Fast Track Designation for Fimepinostat Development in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
In the news release, Curis Announces FDA Fast Track Designation for Fimepinostat (CUDC-907) Development in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma, issued 31-May-2018 by Curis, Inc. over PR Newswire, we are advised by the company that some information that is imperative for the investor community was not included in the original release.
May 31, 2018
·
3 min read
Previous
13 of 27
Next